| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dihydropyrimidinase activity | 1.32e-06 | 6 | 82 | 3 | GO:0004157 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides | 3.60e-05 | 16 | 82 | 3 | GO:0016812 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TBX18 ZNF132 ZSCAN32 ZNF671 ZSCAN12 ZNF154 ZSCAN31 ZNF780A MTOR ZSCAN26 ZNF189 ZSCAN9 ZNF616 ZNF691 | 6.23e-04 | 1271 | 82 | 14 | GO:0000987 |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 7.34e-04 | 10 | 82 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | TBX18 ZNF132 ZNF133 ZSCAN32 ZNF671 ZSCAN12 ZNF154 ZSCAN31 ZNF780A ZNF566 ZSCAN26 ZNF189 ZSCAN9 ZNF616 ZNF691 | 7.97e-04 | 1459 | 82 | 15 | GO:0000977 |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase metabolic process | 1.61e-06 | 22 | 82 | 4 | GO:0006206 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase catabolic process | 3.34e-06 | 8 | 82 | 3 | GO:0006208 | |
| GeneOntologyBiologicalProcess | nucleobase catabolic process | 1.68e-05 | 13 | 82 | 3 | GO:0046113 | |
| GeneOntologyBiologicalProcess | nucleobase metabolic process | 3.05e-05 | 45 | 82 | 4 | GO:0009112 | |
| GeneOntologyBiologicalProcess | negative regulation of lysosome organization | 9.32e-05 | 4 | 82 | 2 | GO:1905672 | |
| MousePheno | abnormal brown adipose tissue thermogenesis | 1.98e-05 | 13 | 59 | 3 | MP:0011699 | |
| Domain | ZINC_FINGER_C2H2_2 | TRERF1 ZNF132 ZNF133 ZSCAN32 ZNF671 ZNF154 ZSCAN31 ZNF780A ZNF804B ZNF566 ZSCAN26 ZBTB8B ZNF189 ZSCAN9 ZNF616 ZNF691 | 8.47e-08 | 775 | 77 | 16 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | TRERF1 ZNF132 ZNF133 ZSCAN32 ZNF671 ZNF154 ZSCAN31 ZNF780A ZNF804B ZNF566 ZSCAN26 ZBTB8B ZNF189 ZSCAN9 ZNF616 ZNF691 | 8.77e-08 | 777 | 77 | 16 | PS00028 |
| Domain | - | TRERF1 ZNF132 ZNF133 ZSCAN32 ZNF671 ZNF154 ZSCAN31 ZNF780A ZNF566 ZSCAN26 ZBTB8B ZNF189 ZSCAN9 ZNF616 ZNF691 | 9.55e-08 | 679 | 77 | 15 | 3.30.160.60 |
| Domain | Znf_C2H2-like | TRERF1 ZNF132 ZNF133 ZSCAN32 ZNF671 ZNF154 ZSCAN31 ZNF780A ZNF804B ZNF566 ZSCAN26 ZBTB8B ZNF189 ZSCAN9 ZNF616 ZNF691 | 1.22e-07 | 796 | 77 | 16 | IPR015880 |
| Domain | zf-C2H2 | TRERF1 ZNF132 ZNF133 ZSCAN32 ZNF671 ZNF154 ZSCAN31 ZNF780A ZNF566 ZSCAN26 ZBTB8B ZNF189 ZSCAN9 ZNF616 ZNF691 | 1.24e-07 | 693 | 77 | 15 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | TRERF1 ZNF132 ZNF133 ZSCAN32 ZNF671 ZNF154 ZSCAN31 ZNF780A ZNF566 ZSCAN26 ZBTB8B ZNF189 ZSCAN9 ZNF616 ZNF691 | 1.27e-07 | 694 | 77 | 15 | IPR013087 |
| Domain | Znf_C2H2 | TRERF1 ZNF132 ZNF133 ZSCAN32 ZNF671 ZNF154 ZSCAN31 ZNF780A ZNF804B ZNF566 ZSCAN26 ZBTB8B ZNF189 ZSCAN9 ZNF616 ZNF691 | 1.42e-07 | 805 | 77 | 16 | IPR007087 |
| Domain | ZnF_C2H2 | TRERF1 ZNF132 ZNF133 ZSCAN32 ZNF671 ZNF154 ZSCAN31 ZNF780A ZNF804B ZNF566 ZSCAN26 ZBTB8B ZNF189 ZSCAN9 ZNF616 ZNF691 | 1.50e-07 | 808 | 77 | 16 | SM00355 |
| Domain | Hydantoinase/dihydroPyrase | 1.34e-06 | 6 | 77 | 3 | IPR011778 | |
| Domain | - | 3.72e-06 | 8 | 77 | 3 | 2.30.40.10 | |
| Domain | zf-C2H2_6 | TRERF1 ZNF133 ZNF671 ZNF154 ZSCAN31 ZNF780A ZNF566 ZSCAN9 ZNF616 | 5.66e-06 | 314 | 77 | 9 | PF13912 |
| Domain | Amidohydro_1 | 7.92e-06 | 10 | 77 | 3 | PF01979 | |
| Domain | Metal-dep_hydrolase_composite | 7.92e-06 | 10 | 77 | 3 | IPR011059 | |
| Domain | Amidohydro-rel | 1.09e-05 | 11 | 77 | 3 | IPR006680 | |
| Domain | KRAB | ZNF132 ZNF133 ZSCAN32 ZNF671 ZNF154 ZNF780A ZNF566 ZNF189 ZNF616 | 1.62e-05 | 358 | 77 | 9 | PS50805 |
| Domain | KRAB | ZNF132 ZNF133 ZSCAN32 ZNF671 ZNF154 ZNF780A ZNF566 ZNF189 ZNF616 | 2.10e-05 | 370 | 77 | 9 | IPR001909 |
| Domain | SCAN | 8.34e-05 | 56 | 77 | 4 | SM00431 | |
| Domain | SCAN_BOX | 9.57e-05 | 58 | 77 | 4 | PS50804 | |
| Domain | SCAN | 9.57e-05 | 58 | 77 | 4 | PF02023 | |
| Domain | SCAN_dom | 9.57e-05 | 58 | 77 | 4 | IPR003309 | |
| Domain | Retrov_capsid_C | 1.02e-04 | 59 | 77 | 4 | IPR008916 | |
| Domain | KRAB | 1.12e-04 | 358 | 77 | 8 | PF01352 | |
| Domain | Metal_Hydrolase | 1.28e-04 | 24 | 77 | 3 | IPR032466 | |
| Domain | KRAB | 1.38e-04 | 369 | 77 | 8 | SM00349 | |
| Domain | Anaphylatoxin_comp_syst | 1.66e-04 | 5 | 77 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.66e-04 | 5 | 77 | 2 | IPR001840 | |
| Domain | ANATO | 3.48e-04 | 7 | 77 | 2 | SM00104 | |
| Domain | ANATO | 3.48e-04 | 7 | 77 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 3.48e-04 | 7 | 77 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 3.48e-04 | 7 | 77 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 3.48e-04 | 7 | 77 | 2 | IPR000020 | |
| Domain | Thiol-ester_cl | 4.62e-04 | 8 | 77 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 4.62e-04 | 8 | 77 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 4.62e-04 | 8 | 77 | 2 | IPR019742 | |
| Domain | LAM_G_DOMAIN | 5.12e-04 | 38 | 77 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 5.96e-04 | 40 | 77 | 3 | PF02210 | |
| Domain | A2M_N | 7.39e-04 | 10 | 77 | 2 | PF01835 | |
| Domain | A2M_N | 7.39e-04 | 10 | 77 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 7.39e-04 | 10 | 77 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 7.39e-04 | 10 | 77 | 2 | PS00477 | |
| Domain | A2M | 7.39e-04 | 10 | 77 | 2 | PF00207 | |
| Domain | A2M_N_2 | 7.39e-04 | 10 | 77 | 2 | IPR011625 | |
| Domain | A2M_comp | 7.39e-04 | 10 | 77 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 7.39e-04 | 10 | 77 | 2 | PF07703 | |
| Domain | A2M_recep | 7.39e-04 | 10 | 77 | 2 | PF07677 | |
| Domain | A2M_comp | 7.39e-04 | 10 | 77 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 7.39e-04 | 10 | 77 | 2 | IPR001599 | |
| Domain | Laminin_G | 1.77e-03 | 58 | 77 | 3 | IPR001791 | |
| Domain | C345C | 2.19e-03 | 17 | 77 | 2 | SM00643 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 2.46e-03 | 18 | 77 | 2 | IPR008930 | |
| Domain | NTR | 2.74e-03 | 19 | 77 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 2.74e-03 | 19 | 77 | 2 | IPR018933 | |
| Domain | NTR | 4.01e-03 | 23 | 77 | 2 | PS50189 | |
| Domain | Netrin_domain | 4.01e-03 | 23 | 77 | 2 | IPR001134 | |
| Domain | HormR | 4.73e-03 | 25 | 77 | 2 | SM00008 | |
| Domain | TIMP-like_OB-fold | 5.11e-03 | 26 | 77 | 2 | IPR008993 | |
| Domain | HRM | 5.92e-03 | 28 | 77 | 2 | PF02793 | |
| Domain | - | 7.11e-03 | 95 | 77 | 3 | 2.60.120.200 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 2.90e-05 | 15 | 58 | 3 | MM15031 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 3.56e-05 | 16 | 58 | 3 | M8245 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 11771764 | ||
| Pubmed | The Ulip family phosphoproteins--common and specific properties. | 5.23e-08 | 4 | 83 | 3 | 9652388 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 10664068 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 8973361 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 10956643 | ||
| Pubmed | CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. | 7.28e-07 | 8 | 83 | 3 | 12134159 | |
| Pubmed | Protein phosphatase 6 regulatory subunits composed of ankyrin repeat domains. | 7.28e-07 | 8 | 83 | 3 | 18186651 | |
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 21187329 | ||
| Pubmed | Rab40c regulates focal adhesions and PP6 activity by controlling ANKRD28 ubiquitylation. | 2.84e-06 | 12 | 83 | 3 | 35512830 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 5.63e-06 | 2 | 83 | 2 | 16565498 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15998580 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 5.63e-06 | 2 | 83 | 2 | 7373044 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19062096 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 5.63e-06 | 2 | 83 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 5.63e-06 | 2 | 83 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 5.63e-06 | 2 | 83 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 5.63e-06 | 2 | 83 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 5.63e-06 | 2 | 83 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 5.63e-06 | 2 | 83 | 2 | 17645767 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 5.63e-06 | 2 | 83 | 2 | 15787745 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12207352 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30026462 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 6559257 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 5.63e-06 | 2 | 83 | 2 | 27758680 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22387014 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 5.63e-06 | 2 | 83 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 5.63e-06 | 2 | 83 | 2 | 20506482 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33764985 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12480675 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 5.63e-06 | 2 | 83 | 2 | 23749435 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23918728 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 5.63e-06 | 2 | 83 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 5.63e-06 | 2 | 83 | 2 | 3037333 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11726230 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 4216347 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 5.63e-06 | 2 | 83 | 2 | 1699796 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 5.63e-06 | 2 | 83 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 5.63e-06 | 2 | 83 | 2 | 2997024 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 5.63e-06 | 2 | 83 | 2 | 3624865 | |
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 5.63e-06 | 2 | 83 | 2 | 8428773 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21857912 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24638111 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 5.63e-06 | 2 | 83 | 2 | 4514997 | |
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 5.63e-06 | 2 | 83 | 2 | 21345967 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 5.63e-06 | 2 | 83 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 5.63e-06 | 2 | 83 | 2 | 3167981 | |
| Pubmed | The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis. | 5.63e-06 | 2 | 83 | 2 | 19234517 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26118640 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 7545960 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30041577 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 2572548 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 2302180 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 5.63e-06 | 2 | 83 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 5.63e-06 | 2 | 83 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 5.63e-06 | 2 | 83 | 2 | 18360261 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 5.63e-06 | 2 | 83 | 2 | 18091514 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 29080553 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25416705 | ||
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 5.63e-06 | 2 | 83 | 2 | 26814963 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 5.63e-06 | 2 | 83 | 2 | 25339671 | |
| Pubmed | TTK regulates proliferation and apoptosis of gastric cancer cells through the Akt-mTOR pathway. | 5.63e-06 | 2 | 83 | 2 | 32530571 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17728371 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 6149580 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 6149581 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12115608 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 3542363 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 2387317 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 8132550 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 2395880 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26814708 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 6192448 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 6167582 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16908004 | ||
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 5.63e-06 | 2 | 83 | 2 | 1438267 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 7365238 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19150565 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 7391573 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17506029 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17971360 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23715124 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 3464002 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 2993295 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 5.63e-06 | 2 | 83 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 5.63e-06 | 2 | 83 | 2 | 17971229 | |
| Pubmed | Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression. | 5.63e-06 | 2 | 83 | 2 | 26418749 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 6881182 | ||
| Pubmed | Identification of the site of sulfation of the fourth component of human complement. | 5.63e-06 | 2 | 83 | 2 | 3944109 | |
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 5.63e-06 | 2 | 83 | 2 | 17921792 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 37479784 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 5.63e-06 | 2 | 83 | 2 | 6978711 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33064845 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 35898513 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33353966 | ||
| Interaction | DPYS interactions | 1.34e-05 | 12 | 81 | 3 | int:DPYS | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF132 ZNF133 ZSCAN32 ZNF671 ZSCAN12 ZNF154 ZSCAN31 ZNF780A ZNF566 ZSCAN26 ZBTB8B ZNF189 ZSCAN9 ZNF616 ZNF691 | 1.72e-08 | 718 | 63 | 15 | 28 |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 8.00e-07 | 6 | 63 | 3 | 699 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.23e-04 | 9 | 63 | 2 | 1234 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.69e-08 | 197 | 83 | 7 | 233b9fcb376e08d0080a05ca0198ecc6ec720f90 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 9.63e-08 | 200 | 83 | 7 | 553386523fd8f8f36617a0d81032224b7ddce442 | |
| ToppCell | Control-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 6.88e-07 | 166 | 83 | 6 | 32ebaefa6c074b28193fff764ee7c2c0e9357e20 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 1.00e-06 | 177 | 83 | 6 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 180 | 83 | 6 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 180 | 83 | 6 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 180 | 83 | 6 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-06 | 184 | 83 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-06 | 184 | 83 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-06 | 184 | 83 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 1.29e-06 | 185 | 83 | 6 | 0af540323c0113203ba6c1a4cb32d2fb9cf79d39 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.33e-06 | 186 | 83 | 6 | 7812ed80d2378aca9957ef22fc3c8fb7fb58434b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-06 | 194 | 83 | 6 | 79baee8b35b7707bbeb07c73b5e17b68bcd7bbc2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-06 | 194 | 83 | 6 | f6e348f1f35c526cad6c349f1fdd0bd92d18aa3c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-06 | 194 | 83 | 6 | ce599ed0dc181aea0584e426636de5098f34ebe6 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-06 | 195 | 83 | 6 | a52685f76eca269a7d2de8dfc317439483e233fa | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-06 | 195 | 83 | 6 | 224deeba2f60def6543a55bb4f5ee6c7fdab3f02 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-06 | 197 | 83 | 6 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-06 | 197 | 83 | 6 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Mesothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.92e-06 | 198 | 83 | 6 | 86736f01e61bf4961f060b24ee1f1f48340737dd | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.97e-06 | 199 | 83 | 6 | ca970114b5aef4518ce580897a62ac88688b2671 | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 1.48e-05 | 166 | 83 | 5 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 1.48e-05 | 166 | 83 | 5 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-05 | 173 | 83 | 5 | 090dc3c5bd2652a65c2490fc889da858c3af368f | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-05 | 174 | 83 | 5 | a79ebb01a5849c314e02594a9c95009dbb03cb8c | |
| ToppCell | ASK452-Immune-B_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.86e-05 | 174 | 83 | 5 | 69723f5666abc3af5f0431901a60246c9915ef81 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.02e-05 | 177 | 83 | 5 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-05 | 179 | 83 | 5 | adf8b025032a03dbb58871a92025cd7efbeb22ff | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 2.19e-05 | 180 | 83 | 5 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.31e-05 | 182 | 83 | 5 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 2.37e-05 | 183 | 83 | 5 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-05 | 183 | 83 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.43e-05 | 184 | 83 | 5 | 804f8a41cd6b1361448872bf352bf0a38a0fac66 | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial-Late_mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.43e-05 | 184 | 83 | 5 | 60dd055c2e2e92b838ac649c12e8cccd9c3b1b71 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-05 | 185 | 83 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-Late_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.69e-05 | 188 | 83 | 5 | 38a53f99f1876359983936403aefca93281d10fd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 188 | 83 | 5 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 2.69e-05 | 188 | 83 | 5 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.76e-05 | 189 | 83 | 5 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-05 | 190 | 83 | 5 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 191 | 83 | 5 | b7713aba839e7a1f548b7b9d8893067bcc6d7ee7 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.98e-05 | 192 | 83 | 5 | ac9e5288ecd4b1e142f2e15a1fcd11c8eb9e15cd | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.13e-05 | 194 | 83 | 5 | 421344cc4b601d9745fa72d0af3124dab11d1d27 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.37e-05 | 197 | 83 | 5 | 1d4ccca2ff46fccb3ac052b5148cb7f94231d65a | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 197 | 83 | 5 | 26888af95a7cc082a1f1218af35b1f07cb9436ed | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 197 | 83 | 5 | 438de7f0d35d81d5f5e41dcef7b2c54b6da03df4 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.62e-05 | 200 | 83 | 5 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.62e-05 | 200 | 83 | 5 | c800f20adedf4ca736c740510889e92d8bf0ba44 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.62e-05 | 200 | 83 | 5 | bf50e30d5cafb71c567e89580f62084d2f894170 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.62e-05 | 200 | 83 | 5 | 5e5ad07679d5dd2ca80249bce9aaf4a95d42187b | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.62e-05 | 200 | 83 | 5 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | TCGA-Mesothelium|World / Sample_Type by Project: Shred V9 | 1.02e-04 | 130 | 83 | 4 | 3ef1733eb57e2a9a3298ce0d65401f19e2084df1 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.06e-04 | 131 | 83 | 4 | d76a7a9b50ee6d24b74494c6f6b88b3506b3f9ad | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 141 | 83 | 4 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 141 | 83 | 4 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 142 | 83 | 4 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.02e-04 | 155 | 83 | 4 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-04 | 158 | 83 | 4 | d72d6527dc50207ddbada262460d3c4bac249a19 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.22e-04 | 159 | 83 | 4 | 1472536eea61d4f13033efe42f128bae1614fa74 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.22e-04 | 159 | 83 | 4 | 2fb1d2ff52920aeb48d048cf29f0cd45f944a73d | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 2.22e-04 | 159 | 83 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.22e-04 | 159 | 83 | 4 | 57df5c9b678a15eb5e025e1a80de2e6769cc13d5 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-04 | 164 | 83 | 4 | d5bb57c321f2973836efc8990449494cc1fb87c7 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 164 | 83 | 4 | 2a230ea066decb798a0e6f2b96c7608c8e608031 | |
| ToppCell | Multiple_Sclerosis-Other-HSPC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.50e-04 | 164 | 83 | 4 | 6af5529507d695b347adee4be5ead70f56c9cf55 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 164 | 83 | 4 | d02d39edd0bfef5a53b814ec6d5f026d41253218 | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.50e-04 | 164 | 83 | 4 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.56e-04 | 165 | 83 | 4 | dc70e050465d1f05bb4115356dc978aa581149b5 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 166 | 83 | 4 | 4d63c758d46e73311b864148c646bf081498dee7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 166 | 83 | 4 | 4160ccf9291072a6e2782f9ad141bc9a9747f3ad | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.68e-04 | 167 | 83 | 4 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.74e-04 | 168 | 83 | 4 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Tnaive/CM_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.74e-04 | 168 | 83 | 4 | c51244b4bdbfd961e2725306aa9cb25dd66d58bd | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 169 | 83 | 4 | 0054f9bfd4d377c7fd94873c1308622051c59a8e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.80e-04 | 169 | 83 | 4 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 169 | 83 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.87e-04 | 170 | 83 | 4 | aaf29c2d4de172d366cbfc863bc741941667dde1 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 170 | 83 | 4 | 81341bf4fe090af70b2091b6b2579ed08d76e22d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.87e-04 | 170 | 83 | 4 | 09bcbc7eb3b1d35cf03f01ce2f2fe37373382dd4 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 171 | 83 | 4 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 2.93e-04 | 171 | 83 | 4 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 171 | 83 | 4 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | Healthy/Control-NK_CD56bright|World / Disease group and Cell class | 2.93e-04 | 171 | 83 | 4 | 79d7efefdae267905af05f3001514b8b6934d86e | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.93e-04 | 171 | 83 | 4 | bdd30100b74e012eec3090799c22635aa57fa91d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-04 | 173 | 83 | 4 | 9f892d756d05e573af018db64edb130ff187ad47 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.06e-04 | 173 | 83 | 4 | 34357f0e22c4b6d84582492c82c1ea733ca8477d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-04 | 174 | 83 | 4 | 165e14cad57e90aa247dcecfaa3c2e8ff2a470ad | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-04 | 174 | 83 | 4 | 4289dfc7613db4bb3d706b9b65d06e84c0c53558 | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.20e-04 | 175 | 83 | 4 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.20e-04 | 175 | 83 | 4 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.20e-04 | 175 | 83 | 4 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 175 | 83 | 4 | 758a1796b823118ce52f989ef5e1076f8c8ac4c5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.20e-04 | 175 | 83 | 4 | d4827b4dfad07f11cbdd47fbed287af1afb9b1b8 | |
| ToppCell | droplet-Liver-LIVER-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 176 | 83 | 4 | 4d2fb51e71bed0d72f3d7f89d395744860885a5f | |
| ToppCell | droplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 176 | 83 | 4 | 4880fa20b50eb10358e08567e08559ef2954f237 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-04 | 176 | 83 | 4 | 03d194c9814e12802cd932afade69e868814cb78 | |
| ToppCell | droplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 176 | 83 | 4 | fcdddd949ca05b3ecde240db9e38296a6eab2d6a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.34e-04 | 177 | 83 | 4 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 177 | 83 | 4 | b41e975e8368e2618b015be095efe8c0e001c78b | |
| Disease | anxiety, stress-related disorder, major depressive disorder | 7.88e-06 | 46 | 81 | 4 | EFO_0005230, EFO_0010098, MONDO_0002009 | |
| Disease | coronary aneurysm | 1.22e-04 | 35 | 81 | 3 | EFO_1000881 | |
| Disease | retinal vasculature measurement | 5.53e-04 | 517 | 81 | 7 | EFO_0010554 | |
| Disease | renal cell carcinoma (is_implicated_in) | 9.16e-04 | 69 | 81 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | sphingosine 1-phosphate measurement | 1.11e-03 | 18 | 81 | 2 | EFO_0800185 | |
| Disease | depressive symptom measurement, response to antidepressant | 1.85e-03 | 88 | 81 | 3 | EFO_0007006, GO_0036276 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RTQSGLQSYLLQFHG | 81 | Q9UNN8 | |
| SGHFQRLLISLSQGN | 331 | P50995 | |
| LHFTSDGNHRQRGFS | 286 | Q7Z408 | |
| GNNNSARLLGVFSHS | 1156 | Q7Z408 | |
| NIQGINLLFSSRRGH | 126 | P0C0L5 | |
| RNLHQSGFSLSGTQV | 531 | Q14195 | |
| HGRFSRSQTIIQSGA | 316 | O15084 | |
| SFSQGHLQNILGNFR | 1411 | Q86UQ4 | |
| GNHLRRGLASVFSNR | 6 | Q8WXI4 | |
| QHGRLGRSFSASFHQ | 461 | Q86UB2 | |
| ATARQHSTFTGRFGQ | 851 | Q9C0I3 | |
| SNQHGIRRNLTAALG | 2406 | Q9HCU4 | |
| HGRFTRSQILIQNGS | 316 | Q8NB46 | |
| RFENHFQTRQDGGSS | 136 | Q9UBS3 | |
| FGQTIQSFTLRGDHR | 116 | Q7Z628 | |
| FTPFLHQRNGNAARS | 226 | Q8NFG4 | |
| VSGALQLLFRHFSQR | 1086 | Q14643 | |
| SLRNRQGQHFCAGSL | 501 | Q2TV78 | |
| NLQRALSAFGAHRGL | 541 | Q9UKN7 | |
| VRNLHQSGFSLSGAQ | 531 | Q16555 | |
| GVSRRRHNSSDGFFN | 41 | Q9HC44 | |
| RFTLSFGHRQNSTGI | 516 | O95528 | |
| LNGHSLTGGRFRQES | 4466 | Q8NDA2 | |
| SFNGTDNHIRFLQQR | 466 | Q5T0W9 | |
| LHGFNLSLQARSGSG | 326 | Q9NYQ8 | |
| GNQDRHFFINSSSGI | 2421 | Q9NYQ8 | |
| NLGLTFLRGSQTQSH | 226 | Q96PD5 | |
| SRRLSFQRDFSGQHN | 156 | Q86YZ3 | |
| HSNFLLANAQGTRGF | 26 | Q9UQ05 | |
| HGRFTRSQTLIQNGG | 316 | Q8N8A2 | |
| LSGGQRHREAFQANF | 266 | Q9H7L2 | |
| AQQRLGSGSFQRHYT | 436 | Q9NZB8 | |
| LNRHLQHSFTRGFSG | 1976 | Q7Z442 | |
| RFGHGNQVSSLLSVR | 781 | Q9UMZ3 | |
| GGFLNAIAHTANTFR | 166 | Q8NGQ1 | |
| GLLRANNLHSGDNFQ | 296 | Q9BZF1 | |
| VRNLHQSGFSLSGSQ | 531 | O14531 | |
| FGNHSTRENLNAGNF | 291 | Q5TEA3 | |
| SSRGRFGVVANNNRH | 1141 | Q9BTC0 | |
| ISHNAAFGTGRAARN | 91 | Q6QHC5 | |
| YRTNTGFLQRLGHNL | 181 | Q8WWU7 | |
| TIHFNQRGTRLASSG | 201 | A6NGE4 | |
| FIRHNSSGSILFLGR | 361 | P30740 | |
| ANGTLTRRHQNGRFV | 56 | O60716 | |
| NIQGINLLFSSRRGH | 126 | P0C0L4 | |
| QGFFRSISLSRGNNL | 1886 | P42345 | |
| TQGLFRGLSRQETHQ | 346 | P82675 | |
| LNLGRRSKIGSNFQH | 436 | Q92581 | |
| SFGHFIARLQGSILQ | 771 | Q9UPR3 | |
| GAARRQFGSNTSLHL | 376 | Q86VY9 | |
| IIGFSNFSQRDQGHS | 286 | Q5HYW2 | |
| NRGTYGTLHLQNSFN | 566 | O43490 | |
| FGGTALTRLNLRNNH | 491 | Q9H156 | |
| GSTAQQFLTFLSHRG | 846 | O15357 | |
| VFGVFSNTQRFLSQH | 76 | Q6ZT89 | |
| NSAEQLFHLNFRGLS | 121 | Q9BSU1 | |
| GLQSAARNHVFFRFN | 6 | Q96E52 | |
| GLQSHRVNNAFLFSI | 111 | Q17RW2 | |
| GRAFSQSSNFLRHQK | 381 | P52740 | |
| GKAFSRNSGLIQHQR | 546 | O75820 | |
| GRRDFSATSGLLQHQ | 246 | Q8TAW3 | |
| CSSHRFNGNSRGNLL | 726 | A4D1E1 | |
| HLRGNNFSGQEASRQ | 26 | Q96LW9 | |
| GKAFNQGSTLNRHQR | 611 | Q08AN1 | |
| GRTFSDISNFGAHQR | 261 | Q5VV52 | |
| GKRFNNSSQFSAHRR | 611 | Q9NX65 | |
| FQQSFQRLSRLGHGS | 106 | Q99640 | |
| FNAALTALGAGQHRT | 236 | Q9H310 | |
| HLLSSGGQQSFFDSR | 576 | O95935 | |
| ARNGSHQVTLRGFSK | 81 | P35590 | |
| LGNESRFHLNRSAAG | 811 | Q96MS0 | |
| KFFRRGSNLNQHRSI | 536 | O75290 | |
| SNSTLNQARNGGRHF | 46 | Q6X4U4 | |
| NQARNGGRHFSNTGL | 51 | Q6X4U4 | |
| EARNSAFGFQGRLLH | 191 | P41273 | |
| EGALQFHRGSRAQSF | 416 | P41587 | |
| CGRGFSQQSNLIRHQ | 471 | P52736 | |
| GEAFRQRSGLFQHQR | 456 | Q16670 | |
| AQESFSGSLGHLQNR | 211 | P33981 | |
| GKAFSSGSNFTRHQR | 261 | Q969W8 | |
| GKSFSQRSALLQHRG | 251 | Q13106 | |
| FSRSSGLFNHRGIHN | 291 | O15535 | |
| RVNRSQSFAGVLGSH | 16 | Q6ZS17 | |
| GNAFRGITSLIQHQR | 531 | O43309 | |
| GAVFSSRQALNGHAR | 1021 | Q96PN7 | |
| TFTSHLSQGLRRFGL | 406 | Q8NAP8 |